U.S.-EU Synergy to Bolster Transatlantic Biotechnology and Biomanufacturing

Continued transatlantic partnership between the United States and the European Union is critical for mutual security, prosperity, and innovation, and the European Commission’s commitment to building the future with biotechnology aligns with ongoing efforts and strategies in the U.S. In the EC’s March 2024 communication, Building the future with nature: Boosting Biotechnology and Biomanufacturing in the EU, the EC identifies challenges within the EU’s biotechnology and biomanufacturing sector and proposes actions to strengthen the EU’s framework. Key challenges outlined by the EC include transferring technologies, navigating a complex regulatory environment, and safeguarding economic security. As the EU and U.S. share similar constraints and concerns when it comes to scaling biomanufacturing and the biotechnology industry, there are opportunities to identify joint solutions and address challenges through partnerships.